542934 — Chandra Bhagat Pharma Income Statement
0.000.00%
Last trade - 00:00- IN₹310.25m
- IN₹510.83m
- IN₹867.16m
Annual income statement for Chandra Bhagat Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 707 | 941 | 1,197 | 2,214 | 867 |
| Cost of Revenue | |||||
| Gross Profit | 110 | 127 | 131 | 133 | 134 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 674 | 915 | 1,166 | 2,291 | 891 |
| Operating Profit | 32.9 | 25.5 | 30.6 | -76.8 | -23.8 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 2.79 | 11 | 11.6 | 22.6 | 11.7 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 1.9 | 7.97 | 9.05 | 15.3 | 8.58 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 1.9 | 7.97 | 9.05 | 15.3 | 8.58 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 1.9 | 7.97 | 9.05 | 15.3 | 8.58 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.25 | 1.14 | 1.29 | 2.1 | 1.14 |